There is accumulating evidence for the existence of a phenotype of isolated cardiac
sarcoidosis (ICS), or sarcoidosis that only involves the heart. In the absence of biopsy …

Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …

Sarcoidosis is a systemic granulomatous disease of unknown cause. Sarcoidosis involving
the heart, ie, cardiac sarcoidosis, affects the prognosis of patients significantly as it may lead …

Clinically evident sarcoidosis involving the heart has been noted in at least 2 to 7% of
patients with sarcoidosis, but occult involvement is much higher (> 20%). Cardiac …

Sarcoidosis is a systemic disease characterized by the development of noncaseating
epithelioid granulomas in multiple organs. Despite extensive investigations over a long …

Heart transplantation (HTx) is a valid therapeutic option for end-stage heart failure
secondary to cardiac sarcoidosis (CS) or giant-cell myocarditis (GCM). However, post-HTx …

Background Patients with end-stage cardiomyopathy due to cardiac sarcoidosis (CS) may
be referred for mechanical circulatory support (MCS) and heart transplantation (HT). We …

Cardiac transplantation (CT) has been one of the great medical advances of the last nearly
50 years. We studied the explanted hearts of 314 patients having CT at Baylor University …

Background: Myocardial injury can be detected more sensitively using 123 I-radioiodinated
15-(p-iodophenyl)-3 (R, S)-methylpentadecanoic acid (BMIPP) than thallium-201 (TL). The …

Described herein are 10 patients who underwent cardiac transplantation (CT) for severe
chronic systolic heart failure resulting from cardiac sarcoidosis. None had the diagnosis of …